PACB Company Profile and Key Details
Pacific Biosciences of California, Inc.
PACB Stock Price Chart
Stock Price Today
Pacific Biosciences of California, Inc. (PACB) stock surged +6.47%, trading at $1.81 on NASDAQ, up from the previous close of $1.70. The stock opened at $1.72, fluctuating between $1.69 and $1.87 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Company Information
| Employees | 796 |
| Beta | 2.01 |
| Sales or Revenue | $200.52M |
| 5Y Sales Change% | 0.357% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Pacific Biosciences of California, Inc. (NASDAQ: PACB) stock price is $1.81 in the last trading session. During the trading session, PACB stock reached the peak price of $1.87 while $1.69 was the lowest point it dropped to. The percentage change in PACB stock occurred in the recent session was 6.47% while the dollar amount for the price change in PACB stock was $0.11.
The NASDAQ listed PACB is part of Medical - Devices industry that operates in the broader Healthcare sector. Pacific Biosciences of California, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Trevin Rard
Head of Investor Relations
Dr. Brett Atkins J.D., Ph.D.
Gen. Counsel & Corporation Sec.
Mr. Christian O. Henry M.B.A.
Pres, Chief Executive Officer & Director
Dr. Denis Zaccarin Ph.D.
Senior Vice President of Product Devel.
Dr. Jonas Korlach Ph.D.
Chief Scientific Officer
Dr. Stephen Turner
Co-Founder & Chief Technology Officer
Ms. Natalie Welch
Chief People Officer
Ms. Susan G. Kim
Chief Financial Officer
Mr. Mike Goloubef
Senior Vice President of Manufacturing & Quality
Mr. Jeff Eidel
Chief Commercial Officer
Mr. Mark Van Oene
Chief Operating Officer
Ms. Michele Farmer CPA
Vice President & Chief Accounting Officer
PACB's closing price is 56.03% higher than its 52-week low of $1.16 where as its distance from 52-week high of $7.50 is -75.87%.
Number of PACB employees currently stands at 796.
Official Website of PACB is: https://www.pacb.com
PACB could be contacted at phone 650 521 8000 and can also be accessed through its website. PACB operates from 1305 O’Brien Drive, Menlo Park, CA 94025, United States.
PACB stock volume for the day was 10.4M shares. The average number of PACB shares traded daily for last 3 months was 10.14M.
The market value of PACB currently stands at $495.69M with its latest stock price at $1.81 and 273.86M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com